Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02368379 · ClinicalTrials.gov registry record · NA
Diagnosis of Central Adrenal Insufficiency in Patients With Prader-Willi Syndrome
A NA study, sponsored by Nationwide Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT02368379: Completed NA study, sponsored by Nationwide Children's Hospital.
NCT02368379 is a NA study that has completed, run by Nationwide Children's Hospital. The registered enrollment target is 23 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02368379, a NA study, has completed, sponsored by Nationwide Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
The purpose of this study is to determine presence of central adrenal insufficiency in children with Prader Willi Syndrome using low dose (1 mcg) ACTH stimulation test compared to results of overnight metyrapone test.
Interventions
- OTHER Low dose (1 mcg) ACTH stimulation test
- OTHER Overnight metyrapone test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2014-03 |
| Est. Completion | 2016-08 |
| Phase | NA |
What the finished NCT02368379 record still lists
NCT02368379 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Low dose (1 mcg) ACTH stimulation test is the first listed.
NCT02368379 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02368379 about?
NCT02368379 is a clinical study titled "Diagnosis of Central Adrenal Insufficiency in Patients With Prader-Willi Syndrome". The purpose of this study is to determine presence of central adrenal insufficiency in children with Prader Willi Syndrome using low dose (1 mcg) ACTH stimulation test compared to results of overnight metyrapone test.
What is the current status of trial NCT02368379?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2014-03. Estimated completion is 2016-08.
What interventions are being tested in trial NCT02368379?
The interventions under investigation include: Low dose (1 mcg) ACTH stimulation test (OTHER), Overnight metyrapone test (OTHER).
Who is sponsoring clinical trial NCT02368379?
This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02368379's enrollment target sits among peer trials
23 1755th of 2000 higher than 245 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia